Janux Therapeutics Inc. (JANX)
Market Open
20 Jul, 13:35
NASDAQ (NMS) NASDAQ (NMS) Primary $
16. 28
+0.02
+0.123%
$
962.33M Market Cap
- P/E Ratio
- Div Yield
21,495 Volume
-1.35 Eps
$ 16.26
Previous Close 
Want to track JANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Janux Therapeutics Inc. (JANX) Statistics
Valuation metrics
Market Cap 962.33M
Enterprise value 961.35M
Trailing P/E (ttm) -8.84
Forward P/E -
PEG ratio 0.26
Price/Sales (ttm) 45.88
Price/Book (mrq) 1.08
Enterprise Value/Revenue 44.48
Enterprise Value/EBITDA -8.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 775.16K
Average volume (90 days) 997.59K
Price summary
52-Week low 12.12
52-Week high 35.34
Beta -
50-Day moving average 14.52
200-Day moving average 14.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.3%
Operating margin -7.26%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 17.01%
Book value per share (mrq) 15.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
